These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33023756)

  • 1. Outcomes for relapsed versus resistant low risk gestational trophoblastic neoplasia following single-agent chemotherapy.
    Jareemit N; Horowitz NS; Goldstein DP; Berkowitz RS; Elias KM
    Gynecol Oncol; 2020 Dec; 159(3):751-757. PubMed ID: 33023756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical analysis of patients with relapsed and chemo-resistant gestational trophoblastic neoplasia].
    Zhou Y; Feng FZ; Xiang Y; Wan XR
    Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):804-7. PubMed ID: 21211275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of extremely high risk and resistant gestational trophoblastic neoplasia patients in King Chulalongkorn Memorial Hospital.
    Oranratanaphan S; Lertkhachonsuk R
    Asian Pac J Cancer Prev; 2014; 15(2):925-8. PubMed ID: 24568520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment results of the second-line chemotherapy regimen for patients with low-risk gestational trophoblastic neoplasia treated with 5-day methotrexate and 5-day etoposide.
    Kanno T; Matsui H; Akizawa Y; Usui H; Shozu M
    J Gynecol Oncol; 2018 Nov; 29(6):e89. PubMed ID: 30207097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [EMA/CO regimen for chemotherapy 24 patients with ultra high-risk gestational trophoblastic neoplasia].
    Shen T; Chen LL; Qin JL; Wang XY; Cheng XD; Xie X; Lyu WG
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):371-376. PubMed ID: 29961278
    [No Abstract]   [Full Text] [Related]  

  • 6. Management and risk factors of recurrent gestational trophoblastic neoplasia: An update from 2004 to 2017.
    Kong Y; Zong L; Cheng H; Jiang F; Wan X; Feng F; Ren T; Zhao J; Yang J; Xiang Y
    Cancer Med; 2020 Apr; 9(7):2590-2599. PubMed ID: 32022487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasia.
    Feng F; Xiang Y; Wan X; Geng S; Wang T
    Ann Oncol; 2011 Jul; 22(7):1588-1594. PubMed ID: 21239399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of patients with relapsed and chemoresistant gestational trophoblastic neoplasia transferred to the Peking Union Medical College Hospital.
    Feng F; Xiang Y; Wan X; Zhou Y
    BJOG; 2010 Jan; 117(1):47-52. PubMed ID: 19874291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study.
    Braga A; Paiva G; Ghorani E; Freitas F; Velarde LGC; Kaur B; Unsworth N; Lozano-Kuehne J; Dos Santos Esteves APV; Rezende Filho J; Amim J; Aguiar X; Sarwar N; Elias KM; Horowitz NS; Berkowitz RS; Seckl MJ
    Lancet Oncol; 2021 Aug; 22(8):1188-1198. PubMed ID: 34181884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia.
    Powles T; Savage PM; Stebbing J; Short D; Young A; Bower M; Pappin C; Schmid P; Seckl MJ
    Br J Cancer; 2007 Mar; 96(5):732-7. PubMed ID: 17299394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and toxicity of second-line actinomycin D in patients with methotrexate-resistant postmolar low-risk gestational trophoblastic neoplasia.
    Maestá I; Nitecki R; Desmarais CCF; Horowitz NS; Goldstein DP; Elias KM; Berkowitz RS
    Gynecol Oncol; 2020 May; 157(2):372-378. PubMed ID: 32037196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk adapted single-agent dactinomycin or carboplatin for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia.
    Winter MC; Tidy JA; Hills A; Ireson J; Gillett S; Singh K; Hancock BW; Coleman RE
    Gynecol Oncol; 2016 Dec; 143(3):565-570. PubMed ID: 27756557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can carboplatin or etoposide replace actinomycin-d for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia?
    Mora PAR; Sun SY; Velarde GC; Filho JR; Uberti EH; Dos Santos Esteves APV; Elias KM; Horowitz NS; Braga A; Berkowitz RS
    Gynecol Oncol; 2019 May; 153(2):277-285. PubMed ID: 30857648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-risk gestational trophoblastic neoplasia outcome after treatment with VMP regimen from 2005 to 2017.
    Zhu CC; Liu HY; Wei Y; Shen Z; Qian LL; Song WG; Wang J; Wu DB; Zhang XF; Zhou Y
    Taiwan J Obstet Gynecol; 2019 May; 58(3):332-337. PubMed ID: 31122520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Clinical Characteristics and Outcomes in 7 Patients with Re-recurrent Gestational Trophoblastic Neoplasia.
    Li B; Wan X; Liang Y; Lu B; Lu W
    J Reprod Med; 2016 Sep; 61(9-10):494-502. PubMed ID: 30383951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to chemotherapy in overweight/obese patients with low-risk gestational trophoblastic neoplasia.
    Maestá I; Horowitz NS; Goldstein DP; Bernstein MR; Ramírez LA; Moulder J; Berkowitz RS
    Int J Gynecol Cancer; 2015 May; 25(4):734-40. PubMed ID: 25675037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of salvage therapy in chemo resistant or recurrent high-risk gestational trophoblastic neoplasm.
    Anantharaju AA; Pallavi VR; Bafna UD; Rathod PS; R VC; K S; Kundargi R
    Int J Gynecol Cancer; 2019 Mar; 29(3):547-553. PubMed ID: 30700567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EMACO for treatment of gestational trophoblastic neoplasia: A multinational multicenter study.
    Jareemit N; Therasakvichya S; Freitas F; Paiva G; Ramírez LAC; Berkowitz RS; Horowitz NS; Maestá I; Fülöp V; Braga A; Elias KM
    Gynecol Oncol; 2023 Mar; 170():114-122. PubMed ID: 36682089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of treatment for low-risk GTN with standard 8-day MTX/FA regimen versus modified MTX/FA regimen without chemotherapy on the weekend.
    Braga A; de Souza Hartung Araújo C; Mora PAR; Paulino E; de Melo AC; Velarde GC; Dos Santos Esteves APV; Junior JA; Filho JR; Elias KM; Horowitz NS; Berkowitz RS
    Gynecol Oncol; 2020 Mar; 156(3):598-605. PubMed ID: 31928806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of women diagnosed and treated for low-risk gestational trophoblastic neoplasia at the Queensland Trophoblast Centre (QTC).
    Verhoef L; Baartz D; Morrison S; Sanday K; Garrett AJ
    Aust N Z J Obstet Gynaecol; 2017 Aug; 57(4):458-463. PubMed ID: 28345753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.